JB Pharma, majority-owned by investment firm KKR & Co., aims to grow its revenue by 12-14% in the next couple of years with a thrust on domestic and contract development and manufacturing organization (CDMO) businesses, its chief executive Nikhil Chopra said. The company is also foraying into new geographies like Europe and Brazil through tie-ups and product launches.
Open Flip
Reported Consolidated quarterly numbers for TITAGARH RAIL SYSTEMS are:Net Sales at Rs 1,052.41 crore in March 2024 up 8.03% from Rs. 974.22 crore in March 2023.Quarterly Net Profit at Rs. 78.95 crore in March 2024 up 63.67% from Rs. 48.24 crore in March 2023.EBITDA stands at Rs. 134.75 crore in March 2024 up 31.48% from Rs. 102.49 crore in March 2023.
Open Flip
Reported Consolidated quarterly numbers for Hindustan Aeronautics are:Net Sales at Rs 14,768.75 crore in March 2024 up 18.2% from Rs. 12,494.67 crore in March 2023.Quarterly Net Profit at Rs. 4,308.71 crore in March 2024 up 52.19% from Rs. 2,831.18 crore in March 2023.EBITDA stands at Rs. 6,458.57 crore in March 2024 up 62.77% from Rs. 3,968.02 crore in March 2023.
Open Flip
